Pure Global
NCT04936477

Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants

Functional Morphometry and Ventilation Perfusion Ratio to Estimate the Alveolar Surface Area in Prematurely Born Infants
King's College London·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bronchopulmonary Dysplasia
Drug/Device/Intervention
Calculation of ventilation-perfusion ratio
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
King's College London
Location
London, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Sep 29, 2020
End date
Aug 31, 2022
Enrollment
30 participants
Primary outcome

Calculation of the alveolar surface area in prematurely born infants using validated functional morphometry

Summary

To non-invasively estimate the alveolar surface area of the lungs of prematurely born infants
 by taking measurements of oxygen and carbon dioxide and utilizing functional morphometry.

ICD-10 classifications
Bronchopulmonary dysplasia originating in the perinatal periodCongenital bronchomalaciaBronchopneumonia, unspecifiedOther congenital malformations of bronchusDiseases of bronchus, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04936477
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04936477 through Pure Global AI's free database. This phase not specified trial is sponsored by King's College London and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.